Literature DB >> 7151331

Characterization of amyloid related protein SAA complexed with serum lipoproteins (apoSAA).

G Marhaug, K Sletten, G Husby.   

Abstract

The amyloid related protein SAA was isolated from the serum lipoproteins of three patients with connective tissue disease, one of them having amyloidosis, and from a pool of normal control sera. The bulk of SAA (apoSAA) was complexed to high density lipoprotein (HDL), but significant amounts of apoSAA were also detected in the other lipoprotein fractions. Electrofocusing revealed five-six subspecies of SAA which were distributed in similar proportions in HDL and LDL. Three of these SAA subspecies made up almost all of the apoSAA present in HDL and LDL in the sera from the patients as well as in the control. A small portion of SAA not complexed to lipoproteins was isolated corresponding to a molecular weight higher than 200,000. No particular 'amyloid prone' SAA was found in serum from the patient with amyloidosis.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7151331      PMCID: PMC1536701     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  14 in total

1.  High-density lipoprotein as carrier for amyloid-related protein SAA in rabbit serum.

Authors:  B Skogen; A L Børresen; J B Natvig; K Berg; T E Michaelsen
Journal:  Scand J Immunol       Date:  1979       Impact factor: 3.487

2.  Isolation and characterization of two threonine-poor apolipoproteins of human plasma high density lipoproteins.

Authors:  V G Shore; B Shore; S B Lewis
Journal:  Biochemistry       Date:  1978-05-30       Impact factor: 3.162

3.  Molecular weight analysis of oligopeptides by electrophoresis in polyacrylamide gel with sodium dodecyl sulfate.

Authors:  R T Swank; K D Munkres
Journal:  Anal Biochem       Date:  1971-02       Impact factor: 3.365

4.  Isolation and characterization of the amyloid-related apoprotein (SAA) from human high density lipoprotein.

Authors:  N Eriksen; E P Benditt
Journal:  Proc Natl Acad Sci U S A       Date:  1980-11       Impact factor: 11.205

5.  Separation and partial characterization of new apoproteins from human plasma high density lipoproteins.

Authors:  C L Malmendier; J Christophe; J P Ameryckx
Journal:  Clin Chim Acta       Date:  1979-12-03       Impact factor: 3.786

Review 6.  Lipid-protein interactions in the plasma lipoproteins.

Authors:  J D Morrisett; R L Jackson; A M Gotto
Journal:  Biochim Biophys Acta       Date:  1977-08-09

7.  Isolation and characterization of amyloid-related serum protein SAA as a low molecular weight protein.

Authors:  R F Anders; J B Natvig; T E Michaelsen; G Husby
Journal:  Scand J Immunol       Date:  1975       Impact factor: 3.487

8.  Amyloid protein SAA is associated with high density lipoprotein from human serum.

Authors:  E P Benditt; N Eriksen
Journal:  Proc Natl Acad Sci U S A       Date:  1977-09       Impact factor: 11.205

9.  A serum component related to nonimmunoglobulin amyloid protein AS, a possible precursor of the fibrils.

Authors:  G Husby; J B Natvig
Journal:  J Clin Invest       Date:  1974-04       Impact factor: 14.808

10.  Heterogeneity of human serum amyloid A proteins.

Authors:  L L Bausserman; P N Herbert; K P McAdam
Journal:  J Exp Med       Date:  1980-09-01       Impact factor: 14.307

View more
  13 in total

1.  Heterogeneity of serum amyloid A with respect to molecular mass.

Authors:  F Ogata
Journal:  Biochem J       Date:  1991-01-01       Impact factor: 3.857

2.  SAA: a link between cholesterol efflux capacity and inflammation?

Authors:  Michael J Thomas; Mary G Sorci-Thomas
Journal:  J Lipid Res       Date:  2015-06-15       Impact factor: 5.922

Review 3.  Reactive (secondary) amyloidosis and its pathogenesis.

Authors:  C P Maury
Journal:  Rheumatol Int       Date:  1984       Impact factor: 2.631

4.  Identification of three isoform patterns of human serum amyloid A protein.

Authors:  A F Strachan; F C de Beer; D R van der Westhuyzen; G A Coetzee
Journal:  Biochem J       Date:  1988-02-15       Impact factor: 3.857

5.  Is the serum amyloid A protein in acute phase plasma high density lipoprotein the precursor of AA amyloid fibrils?

Authors:  M L Baltz; I F Rowe; D Caspi; W G Turnell; M B Pepys
Journal:  Clin Exp Immunol       Date:  1986-12       Impact factor: 4.330

6.  Antibodies to amyloid A protein in rheumatic diseases.

Authors:  C P Maury; A M Teppo
Journal:  Rheumatol Int       Date:  1988       Impact factor: 2.631

7.  Monoclonal hybridoma antibodies to human amyloid related protein SAA.

Authors:  G Marhaug; G Gaudernack; B Bogen; G Husby
Journal:  Clin Exp Immunol       Date:  1982-11       Impact factor: 4.330

8.  Biosynthesis of human acute-phase serum amyloid A protein (A-SAA) in vitro: the roles of mRNA accumulation, poly(A) tail shortening and translational efficiency.

Authors:  D M Steel; J T Rogers; M C DeBeer; F C DeBeer; A S Whitehead
Journal:  Biochem J       Date:  1993-05-01       Impact factor: 3.857

9.  Serum amyloid A, but not C-reactive protein, stimulates vascular proteoglycan synthesis in a pro-atherogenic manner.

Authors:  Patricia G Wilson; Joel C Thompson; Nancy R Webb; Frederick C de Beer; Victoria L King; Lisa R Tannock
Journal:  Am J Pathol       Date:  2008-10-30       Impact factor: 4.307

10.  Serum amyloid A protein (SAA) subtypes in acute and chronic inflammatory conditions.

Authors:  C P Maury; C Ehnholm; M Lukka
Journal:  Ann Rheum Dis       Date:  1985-10       Impact factor: 19.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.